Harvest Fund Management Co.,Ltd - Hkc Innovative Drug ETF (SHA:520970)

Assets	1.05B
Expense Ratio	0.60%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-8.27%

Volume	135,049,700
Open	0.9510
Previous Close	0.9500
Day's Range	0.9370 - 0.9590
52-Week Low	0.6630
52-Week High	1.0960
Beta	n/a
Holdings	44
Inception Date	Jul 30, 2025

About 520970

520970.SS was created on 2025-07-30 by Harvest. The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 520970
• Provider: Harvest
• Index Tracked: CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net

Performance

520970 had a total return of -8.27% in the past year, including dividends. Since the fund's inception, the average annual return has been -6.33%.

Top 10 Holdings

70.52% of assets

Name	Symbol	Weight
WuXi Biologics (Cayman) Inc.	2269	10.61%
Innovent Biologics, Inc.	1801	10.12%
BeOne Medicines AG	6160	9.73%
WuXi AppTec Co., Ltd.	2359	8.35%
Akeso, Inc.	9926	7.13%
CSPC Pharmaceutical Group Limited	1093	6.18%
Hansoh Pharmaceutical Group Company Limited	3692	5.93%
Sino Biopharmaceutical Limited	1177	5.44%
3SBio Inc.	1530	3.77%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	6990	3.28%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error